期刊文献+

奥沙利铂联合卡培他滨治疗老年胃肠恶性肿瘤的临床疗效评析 被引量:7

下载PDF
导出
摘要 目的对奥沙利铂联合卡培他滨在老年胃肠恶性肿瘤中的治疗效果进行分析。方法选取我院2014年9月至2015年9月收治的82例胃肠恶性肿瘤患者作为研究对象,按照双盲法分为参照组和研究组,各41例。参照组予以奥沙利铂联合5-氟尿嘧啶化疗,研究组予以奥沙利铂联合卡培他滨化疗,对两组患者的临床疗效进行记录并对比。结果研究组治疗总有效率为90.24%,参照组为78.05%,差异有统计学意义(P<0.05)。结论采用奥沙利铂联合卡培他滨对老年胃肠恶性肿瘤患者进行化疗,可以有效缓解患者疾病的恶化,从而延长患者的生存时间。
作者 杨友志
出处 《临床医学研究与实践》 2016年第15期90-90,共1页 Clinical Research and Practice
  • 相关文献

参考文献3

二级参考文献23

  • 1金懋林.进展期胃癌全身化学治疗研究新进展[J].癌症进展,2007,5(1):18-24. 被引量:82
  • 2孙燕.肿瘤内科学,人民卫生出版社,2001:264-271.
  • 3Grothey A, Jordan K, Keller O, et al. Randomized phase Ⅱ trial of capecitabine plus irinotecan (Caplri) vs capecitabine plus oxaliplatin (CapOx) as first-line therapy of advanced colorectal cancer(ACRC)[J]. Proc Am Soc Clin Oncol, 2003,22(255):1022.
  • 4Levi F , zidanik, Misser TL, et al. For the international organization for cancer the motherapy; metastatic colorectal cancer[J]. Cancer, 1997,350:681-686.
  • 5wang Senming, Zhang Jiren. The Treatment of irresectable liver tumors by percutaneous targeted Ar-He Cryoablation[J]. International Journal of Modem Cancer Therapy, 2003, 3(1) :16.
  • 6Sumpter K, Harper-Wynne C, Cunningham D, et al.Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer:, a single institution's experience[J].Clin Oncol(R Coil Radiol), 2003, 15(5): 221-226.
  • 7Scheithauer W, Kornek GV, Rader M, et al. Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase Ⅰ/Ⅱ study in first line treatment of patients with advanced colorectal cancer[J]. Ann Oncol,2002, 13(10): 1583.
  • 8Borner MM, Dietrich D, Stupp R. Phase Ⅱ study of capecitabline and oxaliplatin in first and second line treatment of advance on metastatic colocectal cancer[J].Clin Oncol, 2002, 20(7): 1759-1766.
  • 9Twelves C. Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer[J]. Oncology, 2002, 16(Suppl 14): 23-26.
  • 10Al-Batran SE,Hartmann JT,ProbstS,et al.Phase III tr-ial in metastatic gastroesophageal adenocarcinoma with flu-orouraci,l leucovorin plus either oxaliplatin or cisplatin:astudy of the Arbeitsgemeinschaft Internistische Onkologie.JClin Onco,l 2008,26(9):1435-1442.

共引文献17

同被引文献39

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部